BFC Planning’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
BFC Planning's GILD Position: Q3 2026 in Review
BFC Planning increased its Gilead Sciences (GILD) stake by 39% in Q3 2026, buying an estimated $409K and bringing the position to 10,449 shares worth $1.56M. The position accounts for 0.06% of the portfolio, ranked #290.
BFC Planning first reported a position in GILD in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.93M in Q1 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- BFC Planning held 10,449 shares of Gilead Sciences worth $1.56M as of Q3 2026.
- BFC Planning bought 2,912 Gilead Sciences shares in Q3 2026, an estimated $409K.
- Gilead Sciences made up 0.06% of BFC Planning's portfolio in Q3 2026, its #290 holding.
- BFC Planning first reported a position in Gilead Sciences in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Gilead Sciences position peaked at $1.93M in Q1 2026.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.